UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Nature communications, 2022-01, Vol.13 (1), p.69-69, Article 69

2022

Link zum Volltext

Verfügbarkeit prüfen

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

BMC cancer, 2012-01, Vol.12 (1), p.39-39, Article 39

2012

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Link zum Volltext

Verfügbarkeit prüfen

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

NMR in biomedicine, 2012-02, Vol.25 (2), p.369-378

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5126-5137

2005

Link zum Volltext

Verfügbarkeit prüfen

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

Acta oncologica, 2014-10, Vol.53 (10), p.1347-1355

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer

Scientific reports, 2021-12, Vol.11 (1), p.23463-23463, Article 23463

2021

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Journal of steroid biochemistry and molecular biology, 2008-02, Vol.108 (3), p.196-202

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

PloS one, 2012-06, Vol.7 (6), p.e38364

2012

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Molecular cancer, 2010-03, Vol.9 (1), p.68-68, Article 68

2010

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

The New England journal of medicine, 2004-03, Vol.350 (11), p.1081-1092

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

Biomarkers, 2021-05, Vol.26 (4), p.302-308

2021

Link zum Volltext

Verfügbarkeit prüfen

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

European journal of cancer (1990), 2012-09, Vol.48 (13), p.1988-1996

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Link zum Volltext

Verfügbarkeit prüfen

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

NMR in biomedicine, 2012-09, Vol.25 (9), p.1033-1042

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

BMC cancer, 2012-10, Vol.12 (1), p.454-454, Article 454

2012

Link zum Volltext

Verfügbarkeit prüfen

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Nature medicine, 1996-07, Vol.2 (7), p.811-814

1996

Link zum Volltext

Verfügbarkeit prüfen

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors in the treatment of early and advanced breast cancer

Acta oncologica, 2005-01, Vol.44 (1), p.23-31

2005

Link zum Volltext

Verfügbarkeit prüfen

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Maturitas, 1998-01, Vol.28 (3), p.259-265

1998

Link zum Volltext

Verfügbarkeit prüfen

Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

Acta oncologica, 1998, Vol.37 (4), p.365-368

Helge Haarstad, Per E. Lønning, Stein Gundersen, Erik Wist, Nils Raabe, Stener Kvinnsland

1998

Link zum Volltext

Verfügbarkeit prüfen

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

The Journal of steroid biochemistry and molecular biology, 2002-05, Vol.81 (1), p.95-102

2002

Link zum Volltext

Verfügbarkeit prüfen

Multilocus analysis of SNP and metabolic data within a given pathway

BMC genomics, 2006-01, Vol.7 (1), p.5-5, Article 5

2006

Link zum Volltext

Verfügbarkeit prüfen

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Clinical cancer research, 1996-09, Vol.2 (9), p.1515-1521

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

Long-Term Follow-Up of the Intergroup Exemestane Study

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Aromatase inhibitors in the treatment of early and advanced breast cancer

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women

Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

Multilocus analysis of SNP and metabolic data within a given pathway

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Aktive Filter

Suchergebnisse filtern